                               SEQUENCE LISTING

<110> AXON NEUROSCIENCE SE
 
<120> EPITOPE-BASED VACCINES FOR TREATMENT OF CORONAVIRUS ASSOCIATED 
      DISEASES

<130> AXON4-SARSCOV2-P2

<140>
<141>

<150> 63/005,028
<151> 2020-04-03

<160> 227    

<170> PatentIn version 3.5

<210> 1
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Cys Gly Ser Gly Asp Ser Lys Val Gly Gly Asn Tyr Asn Lys Leu Tyr 
1               5                   10                  15      


Arg Leu Phe Glu 
            20  


<210> 2
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 2
Cys Asp Ser Lys Val Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg Gly Pro 
1               5                   10                  15      


Ala Asp Leu Gln Ser Tyr Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr 
            20                  25                  30          


Gln 
    


<210> 3
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Ser Gly Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly 
1               5                   10                  15      


Val Glu Gly Phe Asn Cys Tyr Phe Ala Lys 
            20                  25      


<210> 4
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 4
Cys Val Glu Gly Phe Asn Ala Tyr Phe Pro Leu Gln Ser Tyr Gly Phe 
1               5                   10                  15      


Gln Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr Arg Val Val Val Leu 
            20                  25                  30          


Ser Phe Glu 
        35  


<210> 5
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Gln Ile Leu Pro Asp Pro Ser Lys Pro Ser Lys Arg Ser Cys 
1               5                   10                  


<210> 6
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Cys Asn Gln Lys Leu Ile Ala Asn Gln Phe Asn Ser Ala Ile Gly Lys 
1               5                   10                  15      


Ile Gln Asp Ser Leu Ser Ser 
            20              


<210> 7
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Cys Tyr Thr Met Ser Leu Gly Ala Glu Asn Ser Val Ala Tyr Ser 
1               5                   10                  15  


<210> 8
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Asp Ser Lys Val Gly Gly Asn Tyr Asn Lys Leu Tyr Arg Leu Phe 
1               5                   10                  15  


<210> 9
<211> 13
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 9
Asp Ser Lys Val Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg 
1               5                   10              


<210> 10
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 10
Asp Ser Lys Val Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg Gly Pro Ala 
1               5                   10                  15      


Asp Leu Gln Ser Tyr Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln 
            20                  25                  30          


<210> 11
<211> 15
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 11
Leu Gln Ser Tyr Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln 
1               5                   10                  15  


<210> 12
<211> 22
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 12
Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly Val Glu 
1               5                   10                  15      


Gly Phe Asn Cys Tyr Phe 
            20          


<210> 13
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 13
Val Glu Gly Phe Asn Ala Tyr Phe Pro Leu Gln Ser Tyr Gly Phe Gln 
1               5                   10                  15      


Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr Arg Val Val Val Leu Ser 
            20                  25                  30          


Phe Glu 
        


<210> 14
<211> 13
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 14
Gln Ile Leu Pro Asp Pro Ser Lys Pro Ser Lys Arg Ser 
1               5                   10              


<210> 15
<211> 22
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 15
Asn Gln Lys Leu Ile Ala Asn Gln Phe Asn Ser Ala Ile Gly Lys Ile 
1               5                   10                  15      


Gln Asp Ser Leu Ser Ser 
            20          


<210> 16
<211> 14
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 16
Tyr Thr Met Ser Leu Gly Ala Glu Asn Ser Val Ala Tyr Ser 
1               5                   10                  


<210> 17
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Gly Pro Ala Asp 
1               


<210> 18
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Gly Gly Gly Gly Ser Gly 
1               5       


<210> 19
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly 
1               5                   10                  


<210> 20
<211> 4
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown:
      Factor Xa protease target cleavage region

<400> 20
Ile Glu Gly Arg 
1               


<210> 21
<211> 4
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown:
      Enterokinase protease target cleavage region

<400> 21
Asp Asp Asp Asp 
1               


<210> 22
<211> 5
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown:
      Thrombin protease target cleavage region

<400> 22
Leu Val Pro Arg Gly 
1               5   


<210> 23
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (1)..(20) 
<223> This sequence may encompass 1-4 "Gly Gly Gly Gly Ser"
      repeating units

<400> 23
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly 
1               5                   10                  15      


Gly Gly Gly Ser 
            20  


<210> 24
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (1)..(8) 
<223> This sequence may encompass 6-8 residues

<400> 24
Gly Gly Gly Gly Gly Gly Gly Gly 
1               5               


<210> 25
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (1)..(15) 
<223> This sequence may encompass 1-3 "Glu Ala Ala Ala Lys"
      repeating units

<400> 25
Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys 
1               5                   10                  15  


<210> 26
<211> 46
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 26
Ala Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys 
1               5                   10                  15      


Glu Ala Ala Ala Lys Ala Leu Glu Ala Glu Ala Ala Ala Lys Glu Ala 
            20                  25                  30          


Ala Ala Lys Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys Ala 
        35                  40                  45      


<210> 27
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 27
Pro Ala Pro Ala Pro 
1               5   


<210> 28
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 28
Ala Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys Ala 
1               5                   10          


<210> 29
<211> 68
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MISC_FEATURE
<222> (1)..(68) 
<223> This sequence may encompass 10-34 "Ala Pro"
      repeating units

<400> 29
Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro 
1               5                   10                  15      


Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro 
            20                  25                  30          


Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro 
        35                  40                  45              


Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro 
    50                  55                  60                  


Ala Pro Ala Pro 
65              


<210> 30
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 30
Val Ser Gln Thr Ser Lys Leu Thr Arg Ala Glu Thr Val Phe Pro Asp 
1               5                   10                  15      


Val 
    


<210> 31
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 31
Pro Leu Gly Leu Trp Ala 
1               5       


<210> 32
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 32
Arg Val Leu Ala Glu Ala 
1               5       


<210> 33
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 33
Glu Asp Val Val Cys Cys Ser Met Ser Tyr 
1               5                   10  


<210> 34
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 34
Gly Gly Ile Glu Gly Arg Gly Ser 
1               5               


<210> 35
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 35
Thr Arg His Arg Gln Pro Arg Gly Trp Glu 
1               5                   10  


<210> 36
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 36
Ala Gly Asn Arg Val Arg Arg Ser Val Gly 
1               5                   10  


<210> 37
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 37
Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   


<210> 38
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 38
Gly Phe Leu Gly 
1               


<210> 39
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      8xHis tag

<400> 39
His His His His His His His His 
1               5               


<210> 40
<211> 4
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 40
Arg Arg Ala Arg 
1               


<210> 41
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 41
Gly Ser Ala Ser 
1               


<210> 42
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 42
Asp Ser Lys Val Gly Gly Asn 
1               5           


<210> 43
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 43
Ser Lys Val Gly Gly Asn Tyr 
1               5           


<210> 44
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 44
Lys Val Gly Gly Asn Tyr Asn 
1               5           


<210> 45
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 45
Val Gly Gly Asn Tyr Asn Lys 
1               5           


<210> 46
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 46
Gly Gly Asn Tyr Asn Lys Leu 
1               5           


<210> 47
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 47
Gly Asn Tyr Asn Lys Leu Tyr 
1               5           


<210> 48
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 48
Val Gly Gly Asn Tyr Asn Tyr 
1               5           


<210> 49
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 49
Ala Asp Leu Gln Ser Tyr Gly 
1               5           


<210> 50
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 50
Asp Leu Gln Ser Tyr Gly Phe 
1               5           


<210> 51
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 51
Leu Gln Ser Tyr Gly Phe Gln 
1               5           


<210> 52
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 52
Gln Ser Tyr Gly Phe Gln Pro 
1               5           


<210> 53
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 53
Ser Tyr Gly Phe Gln Pro Thr 
1               5           


<210> 54
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 54
Tyr Gly Phe Gln Pro Thr Asn 
1               5           


<210> 55
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 55
Gly Phe Gln Pro Thr Asn Gly 
1               5           


<210> 56
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 56
Phe Gln Pro Thr Asn Gly Val 
1               5           


<210> 57
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 57
Glu Ile Tyr Gln Ala Gly Ser 
1               5           


<210> 58
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 58
Ile Tyr Gln Ala Gly Ser Thr 
1               5           


<210> 59
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 59
Tyr Gln Ala Gly Ser Thr Pro 
1               5           


<210> 60
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 60
Ala Gly Ser Thr Pro Cys Asn 
1               5           


<210> 61
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 61
Gly Ser Thr Pro Cys Asn Gly 
1               5           


<210> 62
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 62
Ser Thr Pro Cys Asn Gly Val 
1               5           


<210> 63
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 63
Thr Pro Cys Asn Gly Val Glu 
1               5           


<210> 64
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 64
Pro Cys Asn Gly Val Glu Gly 
1               5           


<210> 65
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 65
Cys Asn Gly Val Glu Gly Phe 
1               5           


<210> 66
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 66
Asn Gly Val Glu Gly Phe Asn 
1               5           


<210> 67
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 67
Gly Val Glu Gly Phe Asn Cys 
1               5           


<210> 68
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 68
Pro Leu Gln Ser Tyr Gly Phe 
1               5           


<210> 69
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 69
Gln Pro Thr Asn Gly Val Gly 
1               5           


<210> 70
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 70
Pro Thr Asn Gly Val Gly Tyr 
1               5           


<210> 71
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 71
Thr Asn Gly Val Gly Tyr Gln 
1               5           


<210> 72
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 72
Asn Gly Val Gly Tyr Gln Pro 
1               5           


<210> 73
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 73
Pro Asp Pro Ser Lys Pro Ser 
1               5           


<210> 74
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 74
Asp Pro Ser Lys Pro Ser Lys 
1               5           


<210> 75
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 75
Ile Ala Asn Gln Phe Asn Ser 
1               5           


<210> 76
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 76
Ala Asn Gln Phe Asn Ser Ala 
1               5           


<210> 77
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 77
Asn Gln Phe Asn Ser Ala Ile 
1               5           


<210> 78
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 78
Gln Phe Asn Ser Ala Ile Gly 
1               5           


<210> 79
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 79
Phe Asn Ser Ala Ile Gly Lys 
1               5           


<210> 80
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 80
Asn Ser Ala Ile Gly Lys Ile 
1               5           


<210> 81
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 81
Ser Leu Gly Ala Glu Asn Ser 
1               5           


<210> 82
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 82
Leu Gly Ala Glu Asn Ser Val 
1               5           


<210> 83
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 83
Cys Ser Asn Asn Leu Asp Ser Lys Val Gly Gly Asn Tyr Asn 
1               5                   10                  


<210> 84
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 84
Cys Asp Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr Arg 
1               5                   10                  15      


<210> 85
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 85
Cys Asp Arg Leu Phe Arg Lys Ser Asn Leu Lys Pro Phe Glu 
1               5                   10                  


<210> 86
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 86
Cys Arg Asp Ile Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro 
1               5                   10                  15  


<210> 87
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 87
Cys Ser Pro Gly Gln Thr Gly Lys Ile Ala Asp Tyr Asn Tyr Lys Leu 
1               5                   10                  15      


Pro Asp 
        


<210> 88
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 88
Cys Ser Arg Gly Asp Glu Val Arg Gln Ile Ala Pro Gly Gln Thr Gly 
1               5                   10                  15      


Lys 
    


<210> 89
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 89
Cys Asp Asn Gly Val Glu Gly Phe Asn Gly Tyr Phe Pro Leu Gln Ser 
1               5                   10                  15      


Tyr Gly 
        


<210> 90
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 90
Gly Ser Gly Asp Ser Lys Val Gly Gly Asn Tyr Asn Lys Leu Tyr Arg 
1               5                   10                  15      


Leu Phe Glu Cys 
            20  


<210> 91
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 91
Asp Ser Lys Val Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg Gly Pro Ala 
1               5                   10                  15      


Asp Leu Gln Ser Tyr Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln 
            20                  25                  30          


Cys 
    


<210> 92
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 92
Ser Gly Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly 
1               5                   10                  15      


Val Glu Gly Phe Asn Cys Tyr Phe Ala Lys Cys 
            20                  25          


<210> 93
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 93
Val Glu Gly Phe Asn Ala Tyr Phe Pro Leu Gln Ser Tyr Gly Phe Gln 
1               5                   10                  15      


Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr Arg Val Val Val Leu Ser 
            20                  25                  30          


Phe Glu Cys 
        35  


<210> 94
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 94
Asn Gln Lys Leu Ile Ala Asn Gln Phe Asn Ser Ala Ile Gly Lys Ile 
1               5                   10                  15      


Gln Asp Ser Leu Ser Ser Cys 
            20              


<210> 95
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 95
Tyr Thr Met Ser Leu Gly Ala Glu Asn Ser Val Ala Tyr Ser Cys 
1               5                   10                  15  


<210> 96
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 96
Ser Asn Asn Leu Asp Ser Lys Val Gly Gly Asn Tyr Asn Cys 
1               5                   10                  


<210> 97
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 97
Asp Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr Arg Cys 
1               5                   10                  15      


<210> 98
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 98
Asp Arg Leu Phe Arg Lys Ser Asn Leu Lys Pro Phe Glu Cys 
1               5                   10                  


<210> 99
<211> 15
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 99
Arg Asp Ile Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys 
1               5                   10                  15  


<210> 100
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 100
Ser Pro Gly Gln Thr Gly Lys Ile Ala Asp Tyr Asn Tyr Lys Leu Pro 
1               5                   10                  15      


Asp Cys 
        


<210> 101
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 101
Ser Arg Gly Asp Glu Val Arg Gln Ile Ala Pro Gly Gln Thr Gly Lys 
1               5                   10                  15      


Cys 
    


<210> 102
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 102
Asp Asn Gly Val Glu Gly Phe Asn Gly Tyr Phe Pro Leu Gln Ser Tyr 
1               5                   10                  15      


Gly Cys 
        


<210> 103
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 103
Cys Ser Gly Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn 
1               5                   10                  15      


Gly Val Glu Gly Phe Asn Cys Tyr Phe Ala Lys 
            20                  25          


<210> 104
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 104
Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly Val Glu 
1               5                   10                  15      


Gly Phe Asn Cys Tyr Phe Ala Lys Cys 
            20                  25  


<210> 105
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 105
Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly Val Glu 
1               5                   10                  15      


Gly Phe Asn Cys Tyr Phe Cys 
            20              


<210> 106
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 106
Cys Gln Ile Leu Pro Asp Pro Ser Lys Pro Ser Lys Arg Ser 
1               5                   10                  


<210> 107
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (15)..(15)
<223> Any amino acid

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 107
Cys Asp Ser Lys Val Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg Xaa Leu 
1               5                   10                  15      


Gln Ser Tyr Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln 
            20                  25                  30  


<210> 108
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (14)..(14)
<223> Any amino acid

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 108
Asp Ser Lys Val Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg Xaa Leu Gln 
1               5                   10                  15      


Ser Tyr Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln Cys 
            20                  25                  30  


<210> 109
<211> 12
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 109
Asn Asn Leu Asp Ser Lys Val Gly Gly Asn Tyr Asn 
1               5                   10          


<210> 110
<211> 14
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 110
Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr Arg 
1               5                   10                  


<210> 111
<211> 16
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 111
Pro Gly Gln Thr Gly Lys Ile Ala Asp Tyr Asn Tyr Lys Leu Pro Asp 
1               5                   10                  15      


<210> 112
<211> 15
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 112
Arg Gly Asp Glu Val Arg Gln Ile Ala Pro Gly Gln Thr Gly Lys 
1               5                   10                  15  


<210> 113
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 113
Asn Gly Val Glu Gly Phe Asn Gly Tyr Phe Pro Leu Gln Ser Tyr Gly 
1               5                   10                  15      


<210> 114
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any amino acid

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 114
Asp Ser Lys Val Gly Gly Asn Tyr Asn Xaa Leu Tyr Arg Leu Phe Xaa 
1               5                   10                  15      


<210> 115
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (23)..(23)
<223> Any amino acid

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 115
Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Xaa Asn Gly Val Glu 
1               5                   10                  15      


Gly Phe Asn Cys Xaa Phe Xaa 
            20              


<210> 116
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any amino acid

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 116
Val Glu Gly Phe Asn Xaa Tyr Phe Pro Leu Gln Ser Tyr Gly Phe Gln 
1               5                   10                  15      


Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr Arg Val Val Val Leu Ser 
            20                  25                  30          


Phe Glu 
        


<210> 117
<211> 5
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 117
Tyr Gln Ala Gly Ser 
1               5   


<210> 118
<211> 13
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 118
Ser Asn Asn Leu Asp Ser Lys Val Gly Gly Asn Tyr Asn 
1               5                   10              


<210> 119
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 119
Asp Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr Arg 
1               5                   10                  15  


<210> 120
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 120
Asp Arg Leu Phe Arg Lys Ser Asn Leu Lys Pro Phe Glu 
1               5                   10              


<210> 121
<211> 14
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 121
Arg Asp Ile Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro 
1               5                   10                  


<210> 122
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 122
Ser Pro Gly Gln Thr Gly Lys Ile Ala Asp Tyr Asn Tyr Lys Leu Pro 
1               5                   10                  15      


Asp 
    


<210> 123
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 123
Ser Arg Gly Asp Glu Val Arg Gln Ile Ala Pro Gly Gln Thr Gly Lys 
1               5                   10                  15      


<210> 124
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 124
Asp Asn Gly Val Glu Gly Phe Asn Gly Tyr Phe Pro Leu Gln Ser Tyr 
1               5                   10                  15      


Gly 
    


<210> 125
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 125
Leu Asp Ser Lys Val Gly Gly 
1               5           


<210> 126
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 126
Phe Arg Lys Ser Asn Leu Lys 
1               5           


<210> 127
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 127
Ser Thr Glu Ile Tyr Gln Ala 
1               5           


<210> 128
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 128
Thr Gly Lys Ile Ala Asp Tyr 
1               5           


<210> 129
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 129
Gly Lys Ile Ala Asp Tyr Asn 
1               5           


<210> 130
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 130
Lys Ile Ala Asp Tyr Asn Tyr 
1               5           


<210> 131
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 131
Ile Ala Asp Tyr Asn Tyr Lys 
1               5           


<210> 132
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 132
Asp Glu Val Arg Gln Ile Ala 
1               5           


<210> 133
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 133
Glu Val Arg Gln Ile Ala Pro 
1               5           


<210> 134
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 134
Val Arg Gln Ile Ala Pro Gly 
1               5           


<210> 135
<211> 7
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 135
Arg Gln Ile Ala Pro Gly Gln 
1               5           


<210> 136
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 136
Val Glu Gly Phe Asn Gly Tyr 
1               5           


<210> 137
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 137
Glu Gly Phe Asn Gly Tyr Phe 
1               5           


<210> 138
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 138
Gly Phe Asn Gly Tyr Phe Pro 
1               5           


<210> 139
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 139
Phe Asn Gly Tyr Phe Pro Leu 
1               5           


<210> 140
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 140
Asp Ser Lys Val Gly Gly Asn Tyr Asn Lys Leu Tyr Arg Leu Phe Glu 
1               5                   10                  15      


Gly Ser Gly Cys 
            20  


<210> 141
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 141
Asp Ser Lys Val Gly Gly Asn Tyr Asn Lys Leu Tyr Arg Leu Phe Glu 
1               5                   10                  15      


Asp Ser Gly Cys 
            20  


<210> 142
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 142
Asp Ser Lys Val Gly Gly Asn Tyr Asn Lys Leu Tyr Arg Leu Phe Glu 
1               5                   10                  15      


Asp Gly Cys 
            


<210> 143
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 143
Asp Ser Lys Val Gly Gly Asn Tyr Asn Lys Leu Tyr Arg Leu Phe Glu 
1               5                   10                  15      


Asp Cys 
        


<210> 144
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 144
Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly Val Glu 
1               5                   10                  15      


Gly Phe Asn Cys Tyr Phe Ala Lys Ser Gly Cys 
            20                  25          


<210> 145
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 145
Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly Val Glu 
1               5                   10                  15      


Gly Phe Asn Cys Tyr Phe Ala Lys Ser Asp Gly Cys 
            20                  25              


<210> 146
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 146
Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly Val Glu 
1               5                   10                  15      


Gly Phe Asn Cys Tyr Phe Ala Lys Gly Asp Cys 
            20                  25          


<210> 147
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 147
Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly Val Glu 
1               5                   10                  15      


Gly Phe Asn Cys Tyr Phe Ala Lys Asp Cys 
            20                  25      


<210> 148
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 148
Ser Asp Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly 
1               5                   10                  15      


Val Glu Gly Phe Asn Cys Tyr Phe Ala Lys 
            20                  25      


<210> 149
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 149
Ser Asp Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly 
1               5                   10                  15      


Val Glu Gly Phe Asn Cys Tyr Phe 
            20                  


<210> 150
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 150
Ser Asp Gly Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn 
1               5                   10                  15      


Gly Val Glu Gly Phe Asn Cys Tyr Phe Ala Lys 
            20                  25          


<210> 151
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 151
Ser Asp Gly Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn 
1               5                   10                  15      


Gly Val Glu Gly Phe Asn Cys Tyr Phe 
            20                  25  


<210> 152
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 152
Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly Val Glu 
1               5                   10                  15      


Gly Phe Asn Cys Tyr Phe Gly Cys 
            20                  


<210> 153
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 153
Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly Val Glu 
1               5                   10                  15      


Gly Phe Asn Cys Tyr Phe Gly Asp Cys 
            20                  25  


<210> 154
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 154
Cys Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly Val 
1               5                   10                  15      


Glu Gly Phe Asn Cys Tyr Phe Ala Lys 
            20                  25  


<210> 155
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 155
Cys Asp Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly 
1               5                   10                  15      


Val Glu Gly Phe Asn Cys Tyr Phe Ala Lys 
            20                  25      


<210> 156
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 156
Cys Asp Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly 
1               5                   10                  15      


Val Glu Gly Phe Asn Cys Tyr Phe 
            20                  


<210> 157
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 157
Cys Ser Gln Ile Leu Pro Asp Pro Ser Lys Pro Ser Lys Arg Ser 
1               5                   10                  15  


<210> 158
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 158
Cys Gly Ser Gln Ile Leu Pro Asp Pro Ser Lys Pro Ser Lys Arg Ser 
1               5                   10                  15      


<210> 159
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 159
Gln Ile Leu Pro Asp Pro Ser Lys Pro Ser Lys Arg Ser Asp Cys 
1               5                   10                  15  


<210> 160
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 160
Asn Asn Leu Asp Ser Lys Val Gly Gly Asn Tyr Asn Ser Cys 
1               5                   10                  


<210> 161
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 161
Asn Asn Leu Asp Ser Lys Val Gly Gly Asn Tyr Asn Ser Asp Cys 
1               5                   10                  15  


<210> 162
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 162
Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr Arg Cys 
1               5                   10                  15  


<210> 163
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 163
Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr Arg Asp Cys 
1               5                   10                  15      


<210> 164
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 164
Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr Arg Gly Asp 
1               5                   10                  15      


Cys 
    


<210> 165
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 165
Arg Leu Phe Arg Lys Ser Asn Leu Lys Pro Phe Glu Asp Cys 
1               5                   10                  


<210> 166
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 166
Arg Leu Phe Arg Lys Ser Asn Leu Lys Pro Phe Glu Gly Asp Cys 
1               5                   10                  15  


<210> 167
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 167
Cys Asp Gly Arg Leu Phe Arg Lys Ser Asn Leu Lys Pro Phe Glu 
1               5                   10                  15  


<210> 168
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 168
Pro Gly Gln Thr Gly Lys Ile Ala Asp Tyr Asn Tyr Lys Leu Pro Asp 
1               5                   10                  15      


Cys 
    


<210> 169
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 169
Pro Gly Gln Thr Gly Lys Ile Ala Asp Tyr Asn Tyr Lys Leu Pro Asp 
1               5                   10                  15      


Ser Cys 
        


<210> 170
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 170
Cys Arg Gly Asp Glu Val Arg Gln Ile Ala Pro Gly Gln Thr Gly Lys 
1               5                   10                  15      


<210> 171
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 171
Arg Gly Asp Glu Val Arg Gln Ile Ala Pro Gly Gln Thr Gly Lys Ser 
1               5                   10                  15      


Cys 
    


<210> 172
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 172
Arg Gly Asp Glu Val Arg Gln Ile Ala Pro Gly Gln Thr Gly Lys Ser 
1               5                   10                  15      


Asp Cys 
        


<210> 173
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 173
Asn Gly Val Glu Gly Phe Asn Gly Tyr Phe Pro Leu Gln Ser Tyr Gly 
1               5                   10                  15      


Asp Cys 
        


<210> 174
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 174
Cys Ser Tyr Thr Met Ser Leu Gly Ala Glu Asn Ser Val Ala Tyr Ser 
1               5                   10                  15      


<210> 175
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 175
Cys Asp Ser Tyr Thr Met Ser Leu Gly Ala Glu Asn Ser Val Ala Tyr 
1               5                   10                  15      


Ser 
    


<210> 176
<211> 12
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 176
Arg Leu Phe Arg Arg Ser Asn Leu Lys Pro Phe Glu 
1               5                   10          


<210> 177
<211> 15
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 177
Arg Gly Asp Glu Val Ile Gln Ile Ala Pro Gly Gln Thr Gly Lys 
1               5                   10                  15  


<210> 178
<211> 15
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 178
Arg Gly Asp Glu Val Arg Glu Ile Ala Pro Gly Gln Thr Gly Lys 
1               5                   10                  15  


<210> 179
<211> 15
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 179
Arg Gly Asp Glu Val Ile Glu Ile Ala Pro Gly Gln Thr Gly Lys 
1               5                   10                  15  


<210> 180
<211> 14
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 180
Arg Asp Ile Ser Thr Glu Val Tyr Gln Ala Gly Ser Thr Pro 
1               5                   10                  


<210> 181
<211> 14
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 181
Arg Asp Ile Ser Thr Glu Ile Tyr Gln Ala Ser Ser Thr Pro 
1               5                   10                  


<210> 182
<211> 14
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 182
Arg Asp Ile Ser Thr Glu Val Tyr Gln Ala Ser Ser Thr Pro 
1               5                   10                  


<210> 183
<211> 22
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 183
Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly Ala Glu 
1               5                   10                  15      


Gly Phe Asn Cys Tyr Phe 
            20          


<210> 184
<211> 22
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 184
Ser Thr Glu Ile Tyr Gln Ala Ser Ser Thr Pro Cys Asn Gly Val Glu 
1               5                   10                  15      


Gly Phe Asn Cys Tyr Phe 
            20          


<210> 185
<211> 22
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 185
Ser Thr Glu Val Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly Val Glu 
1               5                   10                  15      


Gly Phe Asn Cys Tyr Phe 
            20          


<210> 186
<211> 22
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 186
Ser Thr Glu Ile Tyr Gln Ala Ser Ser Thr Pro Cys Asn Gly Ala Glu 
1               5                   10                  15      


Gly Phe Asn Cys Tyr Phe 
            20          


<210> 187
<211> 22
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 187
Ser Thr Glu Val Tyr Gln Ala Ser Ser Thr Pro Cys Asn Gly Val Glu 
1               5                   10                  15      


Gly Phe Asn Cys Tyr Phe 
            20          


<210> 188
<211> 22
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 188
Ser Thr Glu Val Tyr Gln Ala Ser Ser Thr Pro Cys Asn Gly Ala Glu 
1               5                   10                  15      


Gly Phe Asn Cys Tyr Phe 
            20          


<210> 189
<211> 16
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 189
Asn Gly Ala Glu Gly Phe Asn Gly Tyr Phe Pro Leu Gln Ser Tyr Gly 
1               5                   10                  15      


<210> 190
<211> 14
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 190
Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln Pro His Arg 
1               5                   10                  


<210> 191
<211> 16
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 191
Asn Gly Val Glu Asp Phe Asn Gly Tyr Phe Pro Leu Gln Ser Tyr Gly 
1               5                   10                  15      


<210> 192
<211> 16
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 192
Asn Gly Val Glu Gly Val Asn Gly Tyr Phe Pro Leu Gln Ser Tyr Gly 
1               5                   10                  15      


<210> 193
<211> 16
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 193
Asn Gly Val Lys Asp Val Asn Gly Tyr Phe Pro Leu Gln Ser Tyr Gly 
1               5                   10                  15      


<210> 194
<211> 16
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 194
Asn Gly Val Glu Gly Phe Asn Gly Tyr Pro Pro Leu Gln Ser Tyr Gly 
1               5                   10                  15      


<210> 195
<211> 16
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 195
Asn Gly Val Glu Gly Phe Asn Gly Tyr Phe Pro Leu Lys Ser Tyr Gly 
1               5                   10                  15      


<210> 196
<211> 13
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 196
Ser Asn Asn Leu Asp Ser Gln Val Gly Gly Asn Tyr Asn 
1               5                   10              


<210> 197
<211> 13
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 197
Ser Asn Asn Leu Asp Ser Lys Ala Gly Gly Asn Tyr Asn 
1               5                   10              


<210> 198
<211> 13
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 198
Ser Asn Asn Leu Asp Ser Lys Val Gly Gly Asn Tyr Asp 
1               5                   10              


<210> 199
<211> 15
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 199
Asp Ser Gln Val Gly Gly Asn Tyr Asn Lys Leu Tyr Arg Leu Phe 
1               5                   10                  15  


<210> 200
<211> 15
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 200
Asp Ser Lys Ala Gly Gly Asn Tyr Asn Lys Leu Tyr Arg Leu Phe 
1               5                   10                  15  


<210> 201
<211> 15
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 201
Asp Ser Lys Val Gly Gly Asn Tyr Asp Lys Leu Tyr Arg Leu Phe 
1               5                   10                  15  


<210> 202
<211> 15
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 202
Asp Ser Lys Val Gly Gly Asn Tyr Asn Lys Leu Phe Arg Leu Phe 
1               5                   10                  15  


<210> 203
<211> 15
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 203
Asp Ser Lys Val Gly Gly Asn Tyr Asn Lys Leu Tyr Arg Phe Phe 
1               5                   10                  15  


<210> 204
<211> 16
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 204
Pro Gly Gln Thr Gly Glu Ile Ala Asp Tyr Asn Tyr Lys Leu Pro Asp 
1               5                   10                  15      


<210> 205
<211> 15
<212> PRT
<213> Severe acute respiratory syndrome coronavirus 2

<400> 205
Arg Gly Asp Glu Val Arg Gln Ile Ala Pro Gly Gln Thr Gly Glu 
1               5                   10                  15  


<210> 206
<211> 27
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown:
      Bacteriophage sequence

<400> 206
Gly Tyr Ile Pro Glu Ala Pro Arg Asp Gly Gln Ala Tyr Val Arg Lys 
1               5                   10                  15      


Asp Gly Glu Trp Val Leu Leu Ser Thr Phe Leu 
            20                  25          


<210> 207
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 207
Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg Gly Pro Ala Asp Leu Gln 
1               5                   10                  15  


<210> 208
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 208
Gly Asn Tyr Asn Tyr Leu Tyr Arg Gly Pro Ala Asp Leu Gln Ser 
1               5                   10                  15  


<210> 209
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 209
Val Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg Gly Pro Ala Asp Leu 
1               5                   10                  15  


<210> 210
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 210
Lys Val Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg Gly Pro Ala Asp 
1               5                   10                  15  


<210> 211
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 211
Ser Lys Val Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg Gly Pro Ala 
1               5                   10                  15  


<210> 212
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 212
Asn Tyr Asn Tyr Leu Tyr Arg Gly Pro Ala Asp Leu Gln Ser Tyr 
1               5                   10                  15  


<210> 213
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 213
Tyr Asn Tyr Leu Tyr Arg Gly Pro Ala Asp Leu Gln Ser Tyr Gly 
1               5                   10                  15  


<210> 214
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 214
Cys Val Glu Gly Phe Asn Ala Tyr Phe Pro Leu Gln Ser Tyr Gly 
1               5                   10                  15  


<210> 215
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 215
Val Glu Gly Phe Asn Ala Tyr Phe Pro Leu Gln Ser Tyr Gly Phe 
1               5                   10                  15  


<210> 216
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 216
Glu Gly Phe Asn Ala Tyr Phe Pro Leu Gln Ser Tyr Gly Phe Gln 
1               5                   10                  15  


<210> 217
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 217
Gly Phe Asn Ala Tyr Phe Pro Leu Gln Ser Tyr Gly Phe Gln Pro 
1               5                   10                  15  


<210> 218
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 218
Phe Asn Ala Tyr Phe Pro Leu Gln Ser Tyr Gly Phe Gln Pro Thr 
1               5                   10                  15  


<210> 219
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 219
Gly Val Gly Tyr Gln Pro Tyr Arg Val Val Val Leu Ser Phe Glu 
1               5                   10                  15  


<210> 220
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 220
Asn Gln Lys Leu Ile Ala Asn Gln Phe Asn Ser Ala Ile Gly Lys 
1               5                   10                  15  


<210> 221
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 221
Gln Lys Leu Ile Ala Asn Gln Phe Asn Ser Ala Ile Gly Lys Ile 
1               5                   10                  15  


<210> 222
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 222
Cys Asn Gln Lys Leu Ile Ala Asn Gln Phe Asn Ser Ala Ile Gly 
1               5                   10                  15  


<210> 223
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 223
Lys Leu Ile Ala Asn Gln Phe Asn Ser Ala Ile Gly Lys Ile Gln 
1               5                   10                  15  


<210> 224
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 224
Val Glu Gly Phe Asn Gly Tyr Phe Pro Leu Gln Ser Tyr 
1               5                   10              


<210> 225
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 225
Glu Gly Phe Asn Gly Tyr Phe Pro Leu Gln Ser Tyr Gly 
1               5                   10              


<210> 226
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 226
Gly Val Glu Gly Phe Asn Gly Tyr Phe Pro Leu Gln Ser 
1               5                   10              


<210> 227
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 227
Cys Asp Tyr Thr Met Ser Leu Gly Ala Glu Asn Ser Val Ala Tyr Ser 
1               5                   10                  15      
